Mason Pairish

17 papers receiving 1.5k citations

Mason Pairish's Hit Papers

Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK) 2011 · 811 citations
8110+5+10Years since publication250500750

Peers

Mason Pairish
Comparison fields: 5 of 65
  • Organic Chemistry 531
  • Computational Theory and Mathematics 269
  • Pulmonary and Respiratory Medicine 434
  • Molecular Biology 340
  • Pathology and Forensic Medicine 86
Replace Yongqin Wan with:
Yongqin Wan United States
Neil B. Grodsky United States
George B. Hill United Kingdom
Shuangying Liu United States
Mitchell D. Nambu United States
Mark A. Ashwell United States
Pei‐Pei Kung United States
Matthew Labenski United States
Yongmi An United States
Wenshuo Lu United States
Mason Pairish relative to Yongqin Wan United States Yongqin Wan's profile →
Citations per field
00.5×1.5×2.0×
Yongqin Wan · 1×
Citations per year

Countries citing papers authored by Mason Pairish

Since Specialization
Citations

This map shows the geographic impact of Mason Pairish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mason Pairish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mason Pairish more than expected).

Fields of papers citing papers by Mason Pairish

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mason Pairish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mason Pairish. The network helps show where Mason Pairish may publish in the future.

Co-authors

The 25 scholars most cited alongside Mason Pairish, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mason Pairish Line = papers co-authored together Mason Pairish links everyone, so they are left out of the graph.

All Works

17 of 17 papers shown
#Work
1
Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)
Hit paper breakdown →
2011811
2 199697
3 201295
4 201685
5 201781
6 201177
7 199762
8 201162
9 201343
10 202038
11 202237
12 201325
13 201222
14 201111
15 20115
16 20124
17 19962

About Mason Pairish

Mason Pairish is a scholar working on Organic Chemistry, Computational Theory and Mathematics, Pulmonary and Respiratory Medicine, Pharmacology and Molecular Biology, having authored 17 papers that have together received 1.6k indexed citations. Recurring topics across this work include Synthesis and biological activity (6 papers), Computational Drug Discovery Methods (4 papers), Lung Cancer Treatments and Mutations (3 papers), Chemical Synthesis and Analysis (3 papers), Prostate Cancer Treatment and Research (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Cancer, Hypoxia, and Metabolism (1 paper). The work is most often cited by research in Organic Chemistry (531 citations), Computational Theory and Mathematics (269 citations), Pulmonary and Respiratory Medicine (434 citations), Molecular Biology (340 citations) and Pathology and Forensic Medicine (86 citations). Mason Pairish has collaborated with scholars based in United States, China and Canada. Frequent co-authors include James S. Nowick, Susan E. Kephart, Chuangxing Guo, Angelica Linton, Martha A. Ornelas, Joseph W. Ziller, Darren L. Holmes, Ying Jiang, Qiyue Hu and Ping Kang. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Journal of the American Chemical Society, Tetrahedron Letters and Chemical Society Reviews.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact